Louisiana Allows 5 mg THC Seltzers. Federal Law Is About to Allow 0.4 mg. Here Is What That Collision Means

Louisiana Revised Statutes 3:1483 sets the state’s ceiling for consumable hemp beverages at five milligrams of total THC per serving, requires a serving to be no less than twelve ounces, and limits a package to four individual containers. Non-beverage consumable hemp packages are capped at forty milligrams of total THC. Retail sale to anyone under twenty-one is prohibited under 3:1482, and sellers need a permit from the Office of Alcohol and Tobacco Control.

Section 781 of Public Law 119-37 narrows the federal hemp definition, replacing the delta-9 threshold with a 0.3 percent total THC standard that counts THCA and adding a cap of 0.4 milligrams of total THC per container on finished products. H.R. 6500, signed September 2, 2026, moved most of those provisions to December 11, 2026 while leaving the exclusion for cannabinoids a cannabis plant cannot naturally produce on the original November 12, 2026 schedule.

Louisiana does not have an operating adult-use dispensary system, and its medical program is narrow. For a large number of adults in the state, permitted hemp beverages have been the regulated cannabis product they could actually buy. If that channel closes, the demand does not close with it.

The clinical risk in a category disappearing is not withdrawal. It is substitution. People replace a five milligram seltzer whose dose they understood with something they do not, and the replacement is more likely to come from an unlabeled source or to be a much higher dose format.

Louisiana’s consumable hemp framework sits in Title 3, Part VI of the Revised Statutes. Under 3:1483, a single serving of a consumable hemp beverage may not exceed five milligrams of total THC, a serving may not be less than twelve ounces, and a package of beverages may not contain more than four individual containers. Non-beverage products are limited to five milligrams per serving and forty milligrams of total THC per package.

The same section bars retail sale of floral hemp material and of inhalable consumable hemp products including vapes, and states that labeling a product not for inhalation does not override a determination that it was designed to be inhaled. Under 3:1482, no one may sell a consumable hemp product at retail to a person under twenty-one, and under 3:1484 a seller needs a permit from the Office of Alcohol and Tobacco Control.

This is a more serious regulatory structure than most states applied to hemp intoxicants, and it is worth saying so plainly. A capped serving size, a minimum volume that dilutes the dose, an age limit, a permit requirement, and a ban on inhalable hemp products are the elements a public health-minded framework would include.

The Louisiana legislature considered further changes in its 2026 regular session. House Bill 539, which addressed consumable hemp products, was withdrawn from the files of the House on May 11, 2026 and did not become law. The statutory picture described above is the one in force.

Section 781 of Public Law 119-37, signed November 12, 2025, rewrites the federal hemp definition. It swaps the delta-9 THC threshold for a 0.3 percent total THC standard that counts THCA, caps finished products at 0.4 milligrams of total THC per container, and excludes products containing cannabinoids that a Cannabis sativa L. plant cannot naturally produce along with cannabinoids the plant could produce but that were synthesized or manufactured outside it.

H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, signed September 2, 2026, pushed most of Section 781 to December 11, 2026. It deliberately left the exclusion for non-naturally-producible and synthesized cannabinoids on the November 12, 2026 schedule. Our companion piece on the DEA drug code for HHC and the two federal hemp deadlines lays out which products fall on which date.

Do the arithmetic on a Louisiana-compliant seltzer. A twelve ounce can holding one five milligram serving contains twelve and a half times the incoming federal per-container limit. Nothing about Louisiana’s permitting structure changes that, because the federal provision operates on the definition of hemp itself. A product that is not hemp is not lawful to sell as hemp anywhere.

The November date matters separately. Delta-9 THC is a cannabinoid the plant naturally produces, so a beverage made from extracted delta-9 is on the December track. A beverage or gummy built on delta-8, HHC, or another converted cannabinoid falls under the exclusion that takes effect November 12.

Hemp beverages became popular partly because the dose is legible. Five milligrams in a twelve ounce can is a number a person can reason about, and the volume itself paces consumption in a way a gummy does not. Patients who have used them for sleep, anxiety, or as an alcohol substitute often know their dose to the milligram, which is more than most cannabis users can say.

When a legible product disappears, people rarely stop. They move to whatever is available: a higher-potency edible, an unlabeled product from an unregulated seller, a trip out of state, or back to alcohol. Each of those carries a different risk profile, and the first two carry dose uncertainty.

The counseling window is now. A patient who uses two five milligram seltzers on a weekend evening is taking ten milligrams of THC orally. That is a useful anchor number to establish before the product is gone, because it lets you have a specific conversation about any replacement rather than a general one.

Swallowed THC is absorbed slowly and passes through the liver before reaching systemic circulation, where a substantial fraction is converted to 11-hydroxy-THC, a metabolite that crosses into the brain readily and is generally more potent than the parent compound. That is why an oral dose can feel stronger and last longer than an inhaled dose of the same size.

Onset typically runs thirty minutes to two hours and can be later with food. The effect often continues to build after a person has concluded that it is not working, which is the mechanism behind most accidental overconsumption. A beverage encourages exactly that error, because drinking has its own social pacing.

The rest holds no matter what the label says: no driving, caution in people with psychotic disorders or unstable cardiovascular disease, attention to sedatives and anticoagulants, and storage away from ordinary drinks. Hemp-derived delta-9 THC is the same molecule dispensaries sell and produces the same result on a urine drug screen.

There are several plausible paths, and no one should be sold a confident forecast. Congress could delay the provisions again, as it did once already in September. It could pass a separate framework for hemp beverages, and bipartisan proposals to do exactly that have been introduced. Enforcement could arrive slowly, as it often does with a definitional change that touches thousands of small retailers. Manufacturers could reformulate toward very low dose products, though a 0.4 milligram container is not a functional intoxicant.

States could also act. Louisiana has a permitting structure, a product registry through the Department of Health, and an age limit already in place, which are the components a state-regulated channel would need if federal law pushes these products out of interstate commerce.

The responsible position for a clinician is to describe the deadline accurately, avoid predicting the outcome, and make sure the patient in front of you knows their own dose well enough to navigate whichever version arrives.

The statutory facts are as solid as facts get. Louisiana’s milligram limits, serving size, age restriction, and permit requirement are in the Revised Statutes and can be read directly. The federal provisions and their revised dates are in public law. Neither depends on anyone’s characterization of the market.

Everything about consequences is forecast. How many products disappear, how quickly enforcement arrives, whether Congress moves the date again, and where consumers go instead are all unknown. Industry estimates of losses come from parties with an obvious interest and should be treated as advocacy rather than measurement.

Coverage of this story has leaned heavily on company revenue figures and predictions of collapse supplied by the companies themselves. Those numbers may be accurate and they are still self-reported by parties with a direct financial stake in the policy outcome. The legal dates are checkable; the commercial forecasts are not.

The opposite framing deserves scrutiny too. Treating the federal cap as an unambiguous public health win assumes consumers move toward safer options rather than toward unlabeled ones. Prohibition of a labeled, dose-capped, age-restricted product does not automatically produce a better outcome than regulating it, and no one has data either way.

None of this establishes that hemp THC beverages are safer than other routes, safer than alcohol, or clinically useful for any condition. Those are separate questions with their own thin evidence base, and a statute changing does not touch them.

It also does not show what will actually happen on December 11, 2026. The provision could be delayed again, enforced unevenly, superseded by a hemp beverage framework, or applied as written. Anyone stating confidently which of those occurs is guessing.

The United States has been running several cannabis markets at once: state medical programs, state adult-use programs, and a hemp-derived intoxicant channel that grew out of a definitional gap in the 2018 farm bill. The federal redefinition is an attempt to close the third one, and Louisiana is a useful test case because it did more than most states to regulate that channel rather than ignore it.

That is the uncomfortable part. The states that wrote real rules for hemp beverages, with dose ceilings, age limits, and permits, lose the same channel as the states that let gas stations sell anything. A federal definitional change does not distinguish between them.

I have patients who found a five milligram seltzer and stopped drinking alcohol on weeknights. I am not going to pretend that is nothing. I am also not going to pretend the category was well regulated everywhere, because in most states it was not, and Louisiana was the exception rather than the rule.

What I tell people now is the same thing I would tell them if nothing were changing: know your milligrams, not your brand. The patients who can tell me the dose they take are the ones who will handle a disruption. The ones who can only tell me the name on the can are the ones who will end up taking something unfamiliar and finding out the hard way that oral THC arrives late.

Louisiana permits hemp beverages at five milligrams of total THC per twelve ounce serving, sold by permitted retailers to adults twenty-one and over. Federal law caps finished hemp products at 0.4 milligrams of total THC per container, with most of Section 781 now effective December 11, 2026 and the synthesized cannabinoid exclusion effective November 12, 2026. Establish your patient’s actual milligram dose now, so any substitution later is a decision rather than an accident.

Carry forward two numbers and two dates: five milligrams per serving under Louisiana law, 0.4 milligrams per container under the amended federal definition, November 12 for synthesized cannabinoids and December 11 for the rest. Do not carry forward any prediction about how the market responds. That part is unknown.